BRPI0510034A - forma de dosagem para distribuição de múltiplas formas de fármacos - Google Patents

forma de dosagem para distribuição de múltiplas formas de fármacos

Info

Publication number
BRPI0510034A
BRPI0510034A BRPI0510034-8A BRPI0510034A BRPI0510034A BR PI0510034 A BRPI0510034 A BR PI0510034A BR PI0510034 A BRPI0510034 A BR PI0510034A BR PI0510034 A BRPI0510034 A BR PI0510034A
Authority
BR
Brazil
Prior art keywords
drug
pharmaceutically acceptable
dosage form
delivery
multiple drug
Prior art date
Application number
BRPI0510034-8A
Other languages
English (en)
Inventor
David E Edgren
Bih-Hsiung Hsu
Shu Li
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of BRPI0510034A publication Critical patent/BRPI0510034A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMA DE DOSAGEM PARA DISTRIBUIçãO DE MúLTIPLAS FORMAS DE FáRMACOS. A presente invenção refere-se as formas de dosagem com Liberação controlada e métodos afins, incluindo: (a) uma forma de base micronizada ou líquida de um fármaco; (b) ou (1) uma forma de sal farmaceuticamente aceitável do fármaco, ou (ii) matérias-primas que são capazes de reagir para formar uma forma de sal farmaceuticamente aceitável do fármaco; (c) uma estrutura de liberação da forma de sai farmaceuticamente aceitável no sistema gastrointestinal superior; e (d) uma estrutura de liberação da forma de base no sistema colónico.
BRPI0510034-8A 2004-05-21 2005-05-20 forma de dosagem para distribuição de múltiplas formas de fármacos BRPI0510034A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57331204P 2004-05-21 2004-05-21
PCT/US2005/017678 WO2005112896A2 (en) 2004-05-21 2005-05-20 Dosage form for delivery of multiple drug forms

Publications (1)

Publication Number Publication Date
BRPI0510034A true BRPI0510034A (pt) 2007-10-02

Family

ID=35159875

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510034-8A BRPI0510034A (pt) 2004-05-21 2005-05-20 forma de dosagem para distribuição de múltiplas formas de fármacos

Country Status (13)

Country Link
US (1) US20050260264A1 (pt)
EP (1) EP1750678A2 (pt)
JP (1) JP2008506788A (pt)
KR (1) KR20070013316A (pt)
CN (1) CN1960709A (pt)
AU (1) AU2005244966A1 (pt)
BR (1) BRPI0510034A (pt)
CA (1) CA2565253A1 (pt)
IL (1) IL179456A0 (pt)
MX (1) MXPA06013397A (pt)
NO (1) NO20065923L (pt)
WO (1) WO2005112896A2 (pt)
ZA (1) ZA200610770B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
US20050287214A1 (en) * 2004-06-28 2005-12-29 Ayer Atul D Squeeze controlled oral dosage form
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
US8637080B2 (en) * 2007-06-28 2014-01-28 Osmotica Kereskedelmi és Szolgáltató, KFT Rupturing controlled release device comprising a subcoat
EP3326621A1 (en) 2007-12-06 2018-05-30 Durect Corporation Oral pharmaceutical dosage forms
JP2011506342A (ja) * 2007-12-06 2011-03-03 ペイン セラピューティクス インコーポレイテッド 微粉化オピオイド組成物、製剤および剤形、ならびにそれらの製造方法
WO2010031552A1 (en) * 2008-09-17 2010-03-25 Niconovum Ab Process for preparing snuff composition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US20120128730A1 (en) * 2010-11-23 2012-05-24 Nipun Davar Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron
US9572885B2 (en) 2013-03-15 2017-02-21 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
SG11201811760VA (en) 2016-07-06 2019-01-30 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
US10716761B2 (en) 2017-07-24 2020-07-21 Alcresta Therapeutics, Inc. Ingestible medical delivery devices
JP2019026726A (ja) * 2017-07-28 2019-02-21 富士ゼロックス株式会社 樹脂組成物及び樹脂成形体
US12161146B2 (en) 2020-02-18 2024-12-10 Intrepid Brands Llc Synthetic fiber oral flavored product
WO2023205692A1 (en) * 2022-04-19 2023-10-26 Intrepid Brands, LLC Liquid formulations for oral flavored product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
NZ537543A (en) * 2002-07-29 2007-08-31 Alza Corp Formulations and high dose osmotic dosage forms for controlled delivery of topiramate

Also Published As

Publication number Publication date
AU2005244966A1 (en) 2005-12-01
US20050260264A1 (en) 2005-11-24
EP1750678A2 (en) 2007-02-14
WO2005112896A2 (en) 2005-12-01
NO20065923L (no) 2007-02-13
JP2008506788A (ja) 2008-03-06
KR20070013316A (ko) 2007-01-30
WO2005112896A3 (en) 2006-05-18
MXPA06013397A (es) 2007-01-23
CA2565253A1 (en) 2005-12-01
ZA200610770B (en) 2008-08-27
CN1960709A (zh) 2007-05-09
IL179456A0 (en) 2007-05-15

Similar Documents

Publication Publication Date Title
BRPI0510034A (pt) forma de dosagem para distribuição de múltiplas formas de fármacos
BRPI0607549A2 (pt) sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos
GT200500384A (es) Formas de dosificacion farmaceutica solidas administrables por via oral con liberacion modificada
CY1119865T1 (el) Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον
CL2007003352A1 (es) Compuestos derivados de heteromonociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades circulatorias, enfermedades metabolicas y/o enfermedades del sistema nervioso cen
CR11740A (es) Composiciones que comprenden fármacos levemente básicos y formas de dosificación de liberación controlada
UY27627A1 (es) Aza - arilpiperazinas
GT200100183A (es) Derivados de quinolina y quinazolina.
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
WO2010127205A3 (en) Fixed dose drug combination formulations
TW200738228A (en) Neramexane modified release matrix tablet
TW200806289A (en) Sustained-release formulation of zonisamide
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
EP1898849A4 (en) NEW PROGRAMS FOR CONTRAZEPTIVE DEVICES WITH CONTROLLED DRUG DELIVERY
DE602004023093D1 (de) N mit einem abgabemittel in mikronisierter form
ZA200807027B (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
DE60205905D1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
BRPI0408918A (pt) formulação parenteral de ácido micofenólico, um sal ou pró-droga do mesmo
WO2006108692A3 (en) Dosage form for oral administration of a vitamin
BRPI0518789A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles
WO2007146068A3 (en) Controlled release alfuzosin hydrochloride formulation
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]